Discover how much money can be saved in your clinical trial!

Biometrics Verification Capabilities

Fingerprint Verification

VCT offers optional biometric fingerprint research subject verification technology that is like no other in the industry to detect professional research subjects in clinical trials. Cutting edge fingerprint verification eliminates issues with fake IDs to detect and prevent professional research subjects at the time of screening. The fingerprint verification improves accuracy and speed reducing transcription errors. VCT never actually collects or stores the actual fingerprint but creates a proprietary reproducible template that is encrypted as well. Easy and cost effective to setup. VCT’s biometric solutions comply with local privacy regulations and can be used around the globe to detect and prevent professional research subjects and duplicate research subjects from entering your clinical trials to improve overall safety and data quality.

  • Optional instant fingerprint biometric authentication
  • Improves speed and accuracy
  • Avoids Fake IDs

Facial Recognition

VCT’s optional facial recognition biometrics can be used for decentralized or virtual clinical trials or can be employed in traditional clinical trials at the research site. Biometric solutions increase speed and accuracy to make VCT the most advanced solution in the quest for optimal research subject selection to detect and prevent professional research subjects in clinical trials.

VCT’s biometric solutions eliminate issues with fake IDs and help select a better qualified subject for your trial. VCT has developed a mobile application platform that allows for fast and easy verifications even as the industry moves towards decentralized and virtual studies. VCT’s facial recognition platform can be utilized on any mobile device or tablet as well as a computer.

VCT’s biometric solutions comply with local privacy regulations and can be used around the globe to detect and prevent professional research subjects and duplicate research subjects from entering your clinical trials to improve overall safety and data quality.